The main finding of the intention-to-treat analysis in this study is the beneficial impact of chemotherapy on the DFS (P = .04) and OS (P = .03) for patients affected by high-risk extremity soft tissue sarcomas and treated with chemotherapy .
The absolute benefit deriving from treatment was a 19% reduction in death at 4 years (P = .04) (Table 5) .
